Pharmacokinetics of NTRX-07 in fed and fasted participants

2025-523695-23-00 Protocol NTRX-07-C110 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 11 Dec 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol NTRX-07-C110

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 24
Countries 1
Sites 1

Not applicable (trial is a pharmacokinetic study in healthy volunteers). Intended indication: neuroinflammation-related diseases, including Alzheimer’s Disease

Key facts

Sponsor
Neurotherapia Inc.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Nervous System Diseases [C10]
Trial duration
11 Dec 2025 → ongoing
Decision date (initial)
2025-11-19
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Not applicable (trial is a pharmacokinetic study in healthy volunteers). Intended indication: neuroinflammation-related diseases, including Alzheimer’s Disease

VersionLevelCodeTermSystem organ class
26.0 LLT 10088820 Clinical trial healthy volunteer 100000004848

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Neurotherapia Inc.

Sponsor organisation
Neurotherapia Inc.
Address
1500 Chagrin River Road
City
Gates Mills
Postcode
44040-7451
Country
United States

Scientific contact point

Organisation
Neurotherapia Inc.
Contact name
Chief Medical Officer (CMO)

Public contact point

Organisation
Neurotherapia Inc.
Contact name
Chief Medical Officer (CMO)

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Hungary Ongoing, recruiting 24 1
Rest of world 0

Investigational sites

Hungary

1 site · Ongoing, recruiting
CRU Hungary Kft.
Early Phase Unit, Semmelweis Ter 1, 2143, Kistarcsa

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Hungary 2025-12-11 2025-12-15

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-09-26 Hungary Acceptable
2025-11-19
2025-11-19